Key takeaways: The FDA granted marketing authorization for a digital cognitive behavioral therapy intervention for adults with type 2 diabetes, according to an industry press release.
Author: Abhay Panchal
Dive Brief:
Becker’s is thrilled to release the 2023 edition of its “Physician leaders to know” list. The physicians featured on this list are exemplary leaders with deep clinical knowledge and experience. Many of them have assumed executive roles at hospitals, health systems or healthcare companies during their careers, while simultaneously serving as community board members or members of national organizations. As physicians, these individuals also bring clinical expertise to their leadership roles, providing them with a thorough understanding of the inner workings of the healthcare system.
When a person has a low IgA level, the tissue transglutaminase immunoglobulin A antibody is no longer a useful screening test for celiac disease. So how should we be assessing patients with an IgA deficiency? To discuss these new recommendations, Dr. Peter Buch is joined by Dr. Claire Jansson-Knodell, Gastroenterologist at the Cleveland Clinic’s Digestive Disease Institute.
CHICAGO – The 2023 Digestive Health Foundation Gala raised $1.6 million to further its mission to fund vital medical research at the Northwestern Medicine Digestive Health Center aimed at improving the quality of life for individuals with digestive disease and their families.
ABSTRACTObjectives: Prior authorization (PA) aims to promote the safe and effective use of medications and to control costs. However, PA-related administrative tasks can contribute to burden on health care providers. This study examines how such tasks affect treatment decisions. Study Design: Cross-sectional, online survey.Methods: We conducted an online survey of US medical providers in 2020 based on a convenience sample of 100,000 providers. Multivariate path analysis was used to examine associations among provider practice characteristics, step therapy and other health plan requirements, perceived burdens of PA, communication issues with insurers, and prescribing behaviors (prescribing a different medication than planned, avoiding…
U.S. Digestive Health CEO Jerry Tillinger recently joined Becker’s to discuss what he thinks will disrupt the gastroenterology industry next. Editor’s note: This response was edited lightly for length and clarity. Question: What will disrupt the GI industry next?Jerry Tillinger: It’s a rapidly moving industry — there’s technology changes, there’s medicine changes and there’s a ton of things that are hitting us all the time. But the one that I think is actually going to drive the most change for us is the rapid growth and the demand for outpatient procedures as we’ve moved the bar for colonoscopy screening from…
According to a new report published by the American Antitrust Institute, private equity (PE) firms have purchased a substantial number of physician practices over the last decade, with some firms owning over 30% of practices in a given specialty in some markets. How private equity is impacting physician practicesIn the report, researchers from the University of California, Berkeley’s Petris Center and the Washington Center for Equitable Growth found that PE acquisitions of physician practices increased more than six-fold between 2012 and 2021. In 2012, there were 75 acquisitions, compared to 484 acquisitions in 2021.
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) has launched Supporting You with UC, an ulcerative colitis (UC) educational campaign with patient ambassador* Rosie White. The Supporting You with UC website includes White’s personal UC diagnosis and treatment journey, along with a collection of practical resources for people living with the disease to help manage symptoms on the go and in their everyday lives.
In a Healio video exclusive, Edward V. Loftus Jr., MD, acknowledged that although artificial intelligence has potential to radically change the way gastroenterologists practice medicine, “it’s not going to replace you.” In the June issue of Healio Gastroenterology, the cover story explores the meteoric rise of AI in medicine, focused on technology capable of engaging text, images and other data to replicate expert medical opinion with the added benefits of standardization, reproducibility and speed. In medical specialties such as gastroenterology and hepatology that rely on extensive imaging studies for early detection and adjustments to patient treatment, the clinical benefits are…